SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-018211
Filing Date
2017-07-12
Accepted
2017-07-12 16:05:31
Documents
1
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3400
  Complete submission text file 0000899243-17-018211.txt   5110
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Issuer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address 324 SOUTH HYDE PARK AVE, SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE, SUITE 350 TAMPA FL 33606 813-864-2557
HedgePath, LLC (Reporting) CIK: 0001584617 (see all company filings)

State of Incorp.: FL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-13467 | Film No.: 17961853